Advertisement
Advertisement
U.S. Markets open in 6 hrs 49 mins
Advertisement
Advertisement
Advertisement
Advertisement

Infinity Pharmaceuticals, Inc. (INFI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
0.6360+0.0008 (+0.13%)
At close: 04:00PM EST
0.6576 +0.02 (+3.40%)
After hours: 06:33PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 2/6/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.43
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.7600
52 Week Low 30.4400
50-Day Moving Average 30.5784
200-Day Moving Average 30.8655

Share Statistics

Avg Vol (3 month) 3703.14k
Avg Vol (10 day) 3341.9k
Shares Outstanding 589.35M
Implied Shares Outstanding 6N/A
Float 875.88M
% Held by Insiders 11.25%
% Held by Institutions 134.83%
Shares Short (Oct 13, 2022) 41.33M
Short Ratio (Oct 13, 2022) 44.45
Short % of Float (Oct 13, 2022) 41.53%
Short % of Shares Outstanding (Oct 13, 2022) 41.50%
Shares Short (prior month Sep 14, 2022) 41.29M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Sep 12, 2006

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,105.32%

Management Effectiveness

Return on Assets (ttm)-35.48%
Return on Equity (ttm)-231.42%

Income Statement

Revenue (ttm)2.22M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)34.00%
Gross Profit (ttm)-30.91M
EBITDA -46.19M
Net Income Avi to Common (ttm)-46.79M
Diluted EPS (ttm)-0.6760
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)56.58M
Total Cash Per Share (mrq)0.63
Total Debt (mrq)1.19M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.16
Book Value Per Share (mrq)-0.36

Cash Flow Statement

Operating Cash Flow (ttm)-41.71M
Levered Free Cash Flow (ttm)-22.54M
Advertisement
Advertisement